Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults

BACKGROUND: Almost 700 cases of human infection with avian influenza A/H7N9 have been reported since 2013. Pandemic preparedness strategies include H7N9 vaccine development. METHODS: We evaluated an inactivated H7N9 vaccine in an observer-blind study in healthy adults aged 18–64 years. Participants...

Descripción completa

Detalles Bibliográficos
Autores principales: Madan, Anuradha, Segall, Nathan, Ferguson, Murdo, Frenette, Louise, Kroll, Robin, Friel, Damien, Soni, Jyoti, Li, Ping, Innis, Bruce L., Schuind, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144728/
https://www.ncbi.nlm.nih.gov/pubmed/27609809
http://dx.doi.org/10.1093/infdis/jiw414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144728/
https://www.ncbi.nlm.nih.gov/pubmed/27609809
http://dx.doi.org/10.1093/infdis/jiw414

Ejemplares similares